Divisas / JNJ
JNJ: Johnson & Johnson
178.38
USD
0.33
(0.18%)
El tipo de cambio de JNJ de hoy ha cambiado un -0.18%. En este caso, el precio mínimo en el mercado ha alcanzado 176.56, mientras que el máximo ha alcanzado 179.50.
Siga la dinámica de la pareja de divisas Johnson & Johnson. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
JNJ News
- Johnson & Johnson: A 6.9 Rating and What It Means for Investors
- September Dogs Of The Dow Unleash One Ideal 'Safer' DiviDog
- Jennifer Taubert, evp of Johnson & Johnson, sells $10m in stock
- Dividend Champion, Contender, And Challenger Highlights: Week Of September 7
- Kenvue fights back against RFK Jr.’s Tylenol safety concerns as its stock tumbles
- BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth?
- Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks (NYSE:PFE)
- Campbell’s appoints Kelly Palumbo as chief accounting officer, details compensation
- Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX?
- Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?
- Guggenheim initiates ORIC Pharmaceuticals stock with Buy rating on cancer drug potential
- Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
- Johnson & Johnson stock price target raised to $195 from $175 at Wolfe Research
- Factbox-Global drugmakers rush to boost US presence as tariff threat looms
- Gilead starts building manufacturing hub under $32 billion planned US investments
- J&J Gears Up for Some Key New Drug Approvals and Launches
- Johnson & Johnson Scores With Heart Pump Breakthrough
- Johnson & Johnson Showcases Positive AFib Data, Treatment Results - Johnson & Johnson (NYSE:JNJ)
- Glaukos Builds Dual Growth Engines Amid Market Headwinds
- Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales
- Johnson & Johnson (JNJ) Says Trial Shows Its Heart Pump Could Keep Patients Alive Longer - TipRanks.com
- Vimian Group AB shares rise after winning $40 million court decision
- These 4 Dividend Stocks Are Money-Printing Machines
- Johnson & Johnson Ends RA Combo After Mid-Stage Miss
Rango diario
176.56
179.50
Rango anual
140.68
181.16
- Cierres anteriores
- 178.71
- Open
- 177.87
- Bid
- 178.38
- Ask
- 178.68
- Low
- 176.56
- High
- 179.50
- Volumen
- 17.019 K
- Cambio diario
- -0.18%
- Cambio mensual
- 0.78%
- Cambio a 6 meses
- 10.98%
- Cambio anual
- 9.77%
07 septiembre, domingo